Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization